Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.
RSV: A New Era in Prevention
In the second installment of the RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.
In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.
In the fourth installment of RSV Roundtable, our panel explains the challenges in protecting the senior population against RSV.
Advertisement
Advertisement
Trending on Contagion Live
1
Developing a COVID-19 Vaccine Alternative
2
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
3
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
4
Building Trust Through Vaccine Education and Science Communication
5
